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1134 Thymoma: A clinicopathologic study based on the new World Health
Organization classification
Kazuo Nakagawa, MD, Hisao Asamura, MD, Yoshihiro Matsuno, MD, Kenji Suzuki, MD,
Haruhiko Kondo, MD, Arafumi Maeshima, MD, Etsuo Miyaoka, PhD, and Ryosuke Tsuchiya,
MD, Tokyo, Japan
A retrospective review of 130 surgically resected thymomas categorized according to the new
WHO histologic classification determined that the classification has clinical and prognostic
value. According to a multivariate analysis, the tumor size, completeness of resection,
histologic subtype, and stage predicted the prognoses of patients with thymoma.
1141 Impact of interstitial lung disease on surgical morbidity and mortality for
lung cancer: Analyses of short-term and long-term outcomes
Masako Chiyo, MD, Yasuo Sekine, MD, Takekazu Iwata, MD, Koichiro Tatsumi, MD,
Kazuhiro Yasufuku, MD, Akira Iyoda, MD, Mizuto Otsuji, MD, Shigetoshi Yoshida, MD,
Kiyoshi Shibuya, MD, Toshihiko Iizasa, MD, Yukio Saitoh, MD, and Takehiko Fujisawa, MD,
Chiba, Japan
Concomitant interstitial lung disease, such as idiopathic pulmonary fibrosis and interstitial
pneumonia due to connective tissue disease, with lung cancer was a risk factor for developing
postoperative morbidity and mortality and poor long-term survival due to the occurrence of
respiratory failure after pulmonary resection for lung cancer.
1147 Tumor necrosis factor inhibitor gene transfer ameliorates lung graft
ischemia-reperfusion injury 
Tsutomu Tagawa, MD, Benjamin D. Kozower, MD, Samer A. Kanaan, MD,
Niccolo` Daddi, MD, Takashi Suda, MD, Tadayuki Oka, MD, and
G. Alexander Patterson, MD, FRCS(C), St Louis, Mo, and Nagasaki, Japan
Adenovirus-mediated gene transfer of soluble type I tumor necrosis factor receptor–IgG fusion
protein increased transgene expression in a rodent lung transplantation model and ameliorated
ischemia-reperfusion injury by improving lung graft oxygenation. Donor endobronchial
transfection was more efficient than recipient intramuscular transfection.
1155 Adenovirus encoding soluble tumor necrosis factor  receptor
immunoglobulin prolongs gene expression of a cotransfected reporter gene
in rat lung 
Takashi Suda, MD, Tsutomu Tagawa, MD, Samer A. Kanaan, MD, Benjamin D. Kozower, MD,
Niccolo` Daddi, MD, T. Mohanakumar, PhD, and G. Alexander Patterson, MD, FRCS(C), St
Louis, Mo
Adenovirus tumor necrosis factor  (TNF-) receptor immunoglobulin and -galactosidase
cotransfection prolonged -galactosidase expression but did not enable successful repeat
administration. The duration of gene expression might be regulated by TNF- rather than
antibody production. Cotransfection of the 2 genes is feasible but could increase antiadenovirus
antibodies and limit repeat vector administration.
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1162 Atrial fibrillation after esophagectomy is a marker for postoperative
morbidity and mortality
Sudish C. Murthy, MD, PhD, Simon Law, MBBChir, MS, FRCSEd, FACS, Brian P. Whooley,
MD, Andreas Alexandrou, MD, Kent-Man Chu, MBBS, MS, FRCSEd, FACS, and John Wong,
PhD, FRACS, FACS, Hong Kong, China, and Cleveland, Ohio
AF is a surrogate for surgical morbidity and mortality after esophagectomy. The occurrence of
AF after esophageal resection should prompt not only the appropriate management of the
arrhythmia but also a search for a more ominous underlying cause.
1168 Survival following intensive preoperative combined modality therapy with
paclitaxel, cisplatin, 5-fluorouracil, and radiation in resectable esophageal
carcinoma: A phase I report
Melvyn Goldberg, MD, Jeffrey Farma, MD, Craig Lampert, MD, Patrick Colarusso, DO,
Lawrence Coia, MD, Harold Frucht, MD, Eric Goosenberg, MD, Mary Beard, and
Louis M. Weiner, MD, Philadelphia, Pa
Twenty-nine patients with resectable esophageal carcinoma were treated with 60 Gy of
radiation and concurrent chemotherapy consisting of continuous 5-fluorouracil and increasing
doses of paclitaxel and cisplatin. At 4-year follow-up 44% were alive and free of disease.
Aggressive combined modality therapy of esophageal carcinoma was associated with excellent




1174 Interleukin 10 gene transfection of donor lungs ameliorates posttransplant
cell death by a switch from cellular necrosis to apoptosis
Stefan Fischer, MD, MSc, Marc de Perrot, MD, MSc, Mingyao Liu, MD,
Alexandra A. MacLean, MD, Jonathan A. Cardella, MSc, Yumiko Imai, MD,
Michiharu Suga, MD, and Shaf Keshavjee, MD, MSc, FRCSC, FACS, Toronto,
Ontario, Canada
Cell death (apoptosis and necrosis) plays a significant role in ischemia-reperfusion injury in
lung transplantation. Adenovirus-mediated IL-10 gene transfection of donor lungs improves
transplanted lung function after prolonged ischemia and is associated with a switch from cell
necrosis to apoptosis in lung grafts.
Brief Communications 1181 Off-pump management of aortic arch aneurysm by using an endovascular
thoracic stent graft ✚
Charles A. Dietl, MD, Karthikeshwar Kasirajan, MD, Stuart B. Pett, MD, and Jorge A. Wernly,
MD, Albuquerque, NM
1184 Relocation of supra-aortic vessels to facilitate endovascular treatment of a
ruptured aortic arch aneurysm ✚
Derk J. Drenth, MD, Eric L. G. Verhoeven, MD, Ted R. Prins, MD, Tjalling W. Waterbolk,
MD, and Piet W. Boonstra, MD, PhD, FECTS, Groningen, The Netherlands
1186 Endovascular flexible stent grafting with arch vessel bypass for a case of
aortic arch aneurysm ✚
Yoshio Nitta, MD, PhD, Yusuke Tsuru, MD, PhD, Kazuhiro Yamaya, MD, Junetsu Akasaka,
MD, PhD, Katsuhiko Oda, MD, PhD, and Koichi Tabayashi, MD, PhD, Sendai, Japan
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1188 Does bridging to transplantation with a left ventricular assist device
adversely affect posttransplantation survival? A comparative analysis of
mechanical versus inotropic support
Jeffrey A. Morgan, MD, YooKyung Park, BS, Aftab R. Kherani, MD, Deon W. Vigilance, MD,
Faisal H. Cheema, MD, Mehmet C. Oz, MD, and Yoshifumi Naka, MD, PhD, New York, NY
1190 Fifteen-month circulatory support for sustained ventricular fibrillation by
left ventricular assist device
Motonobu Nishimura, MD, Masanori Ogiwara, MD, Masayuki Ishikawa, MD, Syogo Yatsu,
MD, Ayumu Masuoka, MD, Nobuyuki Okamura, MD, Kazuhito Imanaka, MD, Masaaki Kato,
MD, Haruhiko Asano, MD, and Shunei Kyo, MD, Saitama, Japan
1192 Combination of the HEARTSTRING proximal seal system with a blower
mister: A possible source of gas emboli
Georg Nollert, MD, Martin Oberhoffer, MD, Bruno Reichart, MD, and Calin Vicol, MD,
Munich, Germany
1194 Life-threatening anaphylactic shock caused by porcine heparin intravenous
infusion during mitral valve repair
Tomaso Bottio, MD, Giorgio Pittarello, MD, Raffaele Bonato, MD, Umberto Fagiolo, MD, and
Gino Gerosa, MD, Padua, Italy
1196 Systolic anterior motion after mitral valve repair: Myectomy as an
alternative solution
Giuseppe Rescigno, MD, Marco L. S. Matteucci, MD, Attilio Iacovoni, MD, Carlo Banfi, MD,
Francesco Seddio, MD, Luca Lorini, MD, Barbara Giamundo, MD, and Paolo Ferrazzi, MD,
Bergamo, Italy
1198 Severe quadricuspid aortic valve stenosis after mediastinal irradiation
Gianclaudio Mecozzi, MD, Stefano Pratali, MD, Aldo Milano, MD, Carmela Nardi, MD, and
Uberto Bortolotti, MD, Pisa, Italy
1199 Chylous leak after cervical mediastinoscopy
Franc¸oise Le Pimpec Barthes, MD, Nicola D’Attellis, MD, Jalal Assouad, MD, Alain Badia,
MD, Redha Souilamas, MD, and Marc Riquet, MD, PhD, Paris, France
1201 Giant parenchymal bronchogenic cyst mimicking hydropneumothorax
Ahmet Basoglu, MD, Burcin Celik, MD, and Aysen Taslak Sengul, MD, Samsun, Turkey
1202 Successful treatment of huge chronic expanding hematoma after
thoracoplasty
Iwao Takanami, MD, Tokyo, Japan
1204 Combined endovascular and video-assisted thoracoscopic procedure for
treatment of a ruptured pulmonary arteriovenous fistula: Case report and
review of the literature
Pierre-Yves Litzler, MD, Franc¸oise Douvrin, MD, Franc¸ois Bouchart, MD, Alfred Tabley, MD,
Ebticem Lemercier, MD, Jean-Marc Baste, MD, Michel Redonnet, MD,
Catherine Haas-Hubscher, MD, Erick Clavier, MD, and Jean-Paul Bessou, MD, Rouen, France
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1207 Fatal air embolism during computed tomography–guided pulmonary
marking with a hook-type marker
Shoji Sakiyama, MD, PhD, Kazuya Kondo, MD, PhD, Hisashi Matsuoka, MD,
Mitsuteru Yoshida, MD, Takanori Miyoshi, MD, PhD, Shusaku Yoshida, MD, PhD,
and Yasumasa Monden, MD, PhD, Tokushima, Japan
1210 Unilateral pulmonary thromboendarterectomy for iatrogenic pulmonary
hypertension in a ten-year-old child
J. Zacharias, FRCS (CTh), S. C. Clark FRCS (CTh), J. R. L. Hamilton, FRCS, J. H. Dark,
FRCS, and A. Hasan, FRCS (CTh), Newcastle upon Tyne, United Kingdom
1212 New material for reconstruction of the anterior chest wall, including the
sternum
Atsushi Watanabe, MD, Toshiaki Watanabe, MD, Takuro Obama, MD, Hisayoshi Ohsawa, MD,
Tooru Mawatari, MD, Yasunori Ichimiya, MD, Noriyuki Takahashi, MD, and Tomio Abe, MD,
Sapporo, Japan
1215 Primary malignant melanoma of the bronchus intermedius
Pier Luigi Filosso, MD, Giovanni Donati, MD, Enrico Ruffini, MD, Sabrina Croce, MD,
Mauro Papotti, MD, Alberto Oliaro, MD, and Maurizio Mancuso, MD, Torino, Italy
1218 Mitral valve replacement by a Gore-Tex reinforced pulmonary autograft in
a child
Masaaki Yamagishi, MD, Keisuke Shuntoh, MD, Tsutomu Matsushita, MD, Katsuji Fujiwara,
MD, Takeshi Shinkawa, MD, Takako Miyazaki, MD, and Nobuo Kitamura, MD, Kyoto, Japan
1220 Surgically created double orifice repair of tricuspid regurgitation in infants
with congenital heart disease
Toyoki Fukuda, MD, Ichiro Kashima, MD, and Shigeki Yoshiba, MD, Tokyo, Japan
1222 The relationship between plasma free 15-F2t–isoprostane concentration and
early postoperative cardiac depression following warm heart surgery
David M. Ansley, MD, Zhengyuan Xia, MD, and Baljinder S. Dhaliwal, MSc, Vancouver,
British Columbia, Canada
Letters to the Editor 1224 Possible Tx N2 M0 atypical bronchial carcinoid associated with Cushing
syndrome
Pier Luigi Filosso, MD, Torino, Italy
1225 Reply
Takafumi Sugawara, MD, Masami Sato, MD, Shulin Wo, MD, and Takashi Kondo, MD,
Sendai, Japan
1225 Spiral pattern: Universe, normal heart, and complex congenital defects
Bruno Marino, MD, and Antonio F. Corno, MD, FRCS, FETCS, Rome, Italy, and Lausanne,
Switzerland
1226 Cardiac transplantation in prisoners
Wayne Richenbacher, MD, Iowa City, Iowa
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